Rockbridge Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-474
Closed -$137K 144
2023
Q4
$137K Buy
+474
New +$129K 0.02% 145
2022
Q3
Sell
-384
Closed -$93.4K 123
2022
Q2
$93.4K Sell
384
-2,316
-86% -$568K 0.02% 169
2022
Q1
$656K Sell
2,700
-90
-3% -$20.7K 0.1% 85
2021
Q4
$628K Buy
2,790
+200
+8% +$42.2K 0.09% 96
2021
Q3
$551K Buy
2,590
+480
+23% +$110K 0.09% 88
2021
Q2
$514K Buy
2,110
+30
+1% +$7.38K 0.09% 93
2021
Q1
$518K Sell
2,080
-67
-3% -$16K 0.1% 83
2020
Q4
$494K Buy
2,147
+67
+3% +$15.4K 0.1% 88
2020
Q3
$529K Buy
2,080
+8
+0.4% +$1.98K 0.13% 78
2020
Q2
$489K Buy
+2,072
New +$473K 0.13% 77

Other funds holding AMGN

Rockbridge Investment Management's AMGN Position: Q1 2024 in Review

Rockbridge Investment Management sold out of Amgen (AMGN) in Q1 2024, closing a stake of 474 shares — an estimated $137K sold.

Rockbridge Investment Management first reported a position in AMGN in Q2 2020 and held it in 10 quarters. The position peaked at $656K in Q1 2022. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Rockbridge Investment Management reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Rockbridge Investment Management sold 474 Amgen shares in Q1 2024, an estimated $137K.
  • Rockbridge Investment Management first reported a position in Amgen in Q2 2020 and held it in 10 quarters.
  • Rockbridge Investment Management's Amgen position peaked at $656K in Q1 2022.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Rockbridge Investment Management's 13F filing for Q1 2024, filed 15 May 2024.